NOTCH2 VUS Interpretation in Pediatric Cholestasis: A 365-Variant Landscape and Genotype–Phenotype Analysis of 7 Cases
Genes · 2026
DOI: 10.3390/genes17101259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Brett J Hoskins und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of…. Hauptthemen laut MEDLINE: Receptor, Notch2, Cholestasis, Alagille Syndrome. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mirum Pharmaceuticals, Inc., Travere Therapeutics (United States), Ipsen (United States).
Abstract (Originalsprache)
Background/Objectives: Interpretation of NOTCH2 variants of uncertain significance (VUSs) remains challenging in pediatric cholestasis and suspected Alagille syndrome (ALGS) due to incomplete penetrance, phenotypic variability, and extensive genetic variation. Although disease-specific variant classification criteria have identified pathogenic hotspots within epidermal growth factor (EGF)-like repeats 8–12 and ankyrin repeat domains 3–6, characterizing these VUSs requires a robust framework.
Methods
We reviewed aggregate deidentified data from 519 multigene cholestasis panel entries and evaluated genotype–phenotype data from a consortium cohort of 7 pediatric patients with heterozygous NOTCH2 VUSs using a clinical–genomic prioritization framework informed by disease-specific ACMG criteria and domain location.
Results
Across the 519 entries, 365 unique NOTCH2 VUSs were identified, none of which overlapped with 69 previously reported ALGS-associated variants or localized to established hotspots, with over 60% occurring outside recognized functional domains. Among the 7 consortium cases, one patient carrying a cysteine-altering variant (p.Cys593Arg) in EGF-like domain 15 demonstrated a strong ALGS-compatible phenotype, while alternative diagnoses in other cases included trisomy 21 and congenital hepatic fibrosis with polycystic kidney disease.
Conclusions
Among 365 unique NOTCH2 VUSs identified through pediatric cholestasis panel testing, none overlapped with previously reported ALGS-associated variants or localized to established pathogenic hotspots. However, a cysteine-altering variant outside canonical hotspots occurred in a patient with a strong ALGS-compatible phenotype, highlighting the importance of integrating variant characteristics, domain location, detailed phenotyping, and alternative diagnoses when prioritizing NOTCH2 VUSs for further evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Mirum Pharmaceuticals, Inc., Foster City, CA 94404, USA.
- Department of Gastroenterology, Johns Hopkins All Children's Hospital, St. Petersburg, FL 33701, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Mercy-Kansas City, Kansas City, MO 64108, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Nebraska Medical Center, Omaha, NE 68198, USA.
ORCID-Profile: Brett J Hoskins, Ruben E Quiros-Tejeira, Wikrom Karnsakul
Förderung
- Mirum Pharmaceuticals, Inc.
- Travere Therapeutics (United States)
- Ipsen (United States)
- Albireo Pharma
Zitieren
APA
Hoskins, B. J., Pramparo, T., Vandriel, S. M., Jarasvaraparn, C., Wilsey, M. J., Slowik, V., Kunam, L., Stoll, J. M., Quiros-Tejeira, R. E., Lam, S., & Karnsakul, W. (2026). NOTCH2 VUS Interpretation in Pediatric Cholestasis: A 365-Variant Landscape and Genotype–Phenotype Analysis of 7 Cases. Genes. https://doi.org/10.3390/genes17101259
Vancouver
Hoskins BJ, Pramparo T, Vandriel SM, Jarasvaraparn C, Wilsey MJ, Slowik V, et al. NOTCH2 VUS Interpretation in Pediatric Cholestasis: A 365-Variant Landscape and Genotype–Phenotype Analysis of 7 Cases. Genes. 2026. doi:10.3390/genes17101259
BibTeX
@article{Hoskins2026,
author = {Hoskins, Brett J and Pramparo, Tiziano and Vandriel, Shannon M and Jarasvaraparn, Chaowapong and Wilsey, Michael J and Slowik, Voytek and Kunam, Lakshmi and Stoll, Janis M and Quiros-Tejeira, Ruben E and Lam, Simon and Karnsakul, Wikrom},
title = {NOTCH2 VUS Interpretation in Pediatric Cholestasis: A 365-Variant Landscape and Genotype–Phenotype Analysis of 7 Cases},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17101259}
}
EUVIMED